You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tumor progression

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain Cancer Trial in New York (PET scan, C-Choline)

Completed
  • Brain Cancer
  • PET scan
  • C-Choline
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 9, 2022

Oral Malignancies and Database and Biospecimen Collection to

Active, not recruiting
  • Oral Cancer
    • Buffalo, New York
      Roswell Park Cancer Institute
    Feb 28, 2022

    1 asPotential Biomarker for Colorectal Cancer Diagnosis and

    Not yet recruiting
    • Colorectal Cancer
    • Tumor Endothelial Marker 1 ( TEM1 ) by ELISA kits
    • (no location specified)
    Mar 20, 2023

    Brain Tumor Trial in Boston (MRI)

    Recruiting
    • Brain Tumor
    • MRI
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jul 18, 2022

    Non-Muscle Invasive Bladder Cancer, Self Efficacy, Smoking Behaviors Trial in Istanbul (Behavioral: Motivational Interviewing

    Not yet recruiting
    • Non-Muscle Invasive Bladder Cancer
    • +4 more
    • Behavioral: Motivational Interviewing with WhatsApp video call
    • Istanbul, Turkey
      İrem Nur Ozdemir
    Jan 20, 2023

    Brain Metastases Trial (MRI perfusion sequence)

    Not yet recruiting
    • Brain Metastases
    • MRI perfusion sequence
    • (no location specified)
    May 9, 2022

    Glioma, High Grade Glioma, Glioma, Malignant Trial in Philadelphia (18F-Fluciclovine PET-MRI)

    Recruiting
    • Glioma
    • +4 more
    • 18F-Fluciclovine PET-MRI
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Dec 22, 2022

    Clinical Outcome of AIS With Active Cancer

    Recruiting
    • Ischemic Stroke, Acute
    • Tumor Progression
    • intestinal flora disturbance
    • Guangzhou, Guangdong, China
      Nanfang Hospital,Southern Medical University
    Sep 18, 2022

    Microbiome in Colorectal Cancer Onset and Progression

    Terminated
    • Colorectal Cancer
    • +4 more
      • Bellevue, Washington
        Washington Gastroenterology
      Dec 23, 2022

      NSCLC (NSCLC) Trial in Shanghai (Tumor treating fields(EFE-P100), Docetaxel injection)

      Not yet recruiting
      • Non-small Cell Lung Cancer (NSCLC)
      • Tumor treating fields（EFE-P100）
      • Docetaxel injection
      • Shanghai, China
        Shanghai Pulmonary Hospital
      Dec 21, 2022

      Metastatic Cancer, Solid Tumor Cancer, Lymphoproliferative Disorders Trial in Boulder (Written Exposure Therapy)

      Recruiting
      • Metastatic Cancer
      • +5 more
      • Written Exposure Therapy
      • Boulder, Colorado
        University of Colorado Boulder
      Sep 13, 2023

      Neuroblastoma, CNS Tumor, Sarcoma Trial in Columbus (Cabozantinib)

      Recruiting
      • Neuroblastoma
      • +2 more
      • Columbus, Ohio
        Nationwide Children's Hospital
      Dec 20, 2022

      Glioma Glioblastoma Multiforme Trial in Philadelphia (Axumin, Intravenous Solution)

      Completed
      • Glioma Glioblastoma Multiforme
      • Axumin, Intravenous Solution
      • Philadelphia, Pennsylvania
        Hospital of the University of Pennsylvania
      Dec 21, 2021

      Liver Cancer Trial in New York (CT guided percutaneous ablation)

      Recruiting
      • Liver Cancer
      • CT guided percutaneous ablation
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Apr 13, 2022

      Glutamate Excitotoxicity and Its Role in Glioblastoma Biology

      Recruiting
      • Brain Tumor, Primary
      • Blood, CSF and tumor samples
      • Milan, Italy
        IRCCS San Raffaele Scientific Institute
      Mar 16, 2023

      HER2-overexpressed Advanced Solid Tumors After Progression of

      Not yet recruiting
      • HER2
      • +3 more
      • Disitamab Vedotin
      • Beijing, Beijing, China
        Beijing Cancer Hospital
      Dec 14, 2022

      Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues

      Active, not recruiting
      Has Results
      • Castration-Resistant Prostate Carcinoma
      • +6 more
      • San Francisco, California
      • +1 more
      Sep 20, 2022

      Solid Tumor Trial in Beijing (GLS-012, GLS-010)

      Recruiting
      • Solid Tumor
      • Beijing, China
        Beijing Cancer Hospital
      Jun 11, 2023

      Secondary Malignant Tumor of Brain and Cerebral Meninges Trial in Cleveland (18F-fluciclovine, PET/CT of the brain)

      Completed
      • Secondary Malignant Neoplasm of Brain and Cerebral Meninges
      • Cleveland, Ohio
        Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
      May 3, 2021

      Metastatic Melanoma, Skin Cancer Trial in Boston (Ipilimumab, Nivolumab, Cryoablation)

      Not yet recruiting
      • Metastatic Melanoma
      • Skin Cancer
      • Boston, Massachusetts
        Massachusetts General Hospital Cancer Center
      Mar 9, 2023

      EMT on CTCs and Disease Progression in Prostate Cancer

      Active, not recruiting
      • Prostate Cancer
      • CellSearch CTC platform
      • Parsortix CTC platform
      • London, Ontario, Canada
        London Regional Cancer Program
      Mar 5, 2022

      Melanoma, Non Small Cell Lung Cancer, Renal Cancer Trial in Clermont-Ferrand (Blood sample)

      Recruiting
      • Melanoma
      • +2 more
      • Blood sample
      • Clermont-Ferrand, France
        CHU de Clermont-Ferrand
      Jun 16, 2022

      Soft Tissue Sarcoma, Adult Soft Tissue Sarcoma, Resectable Soft Tissue Sarcoma Trial in Lyon (radiation, other, procedure)

      Not yet recruiting
      • Soft Tissue Sarcoma
      • +2 more
      • Neoadjuvant RT
      • +3 more
      • Lyon, Rhône, France
        Centre Léon Bérard
      Jan 12, 2023

      Glioblastoma Trial in Zürich (L19TNF, Lomustine)

      Recruiting
      • Glioblastoma
      • Zürich, Switzerland
        Universitatspital Zurich - Klinik fur Neurologie & Hirntumorzent
      Apr 19, 2022

      Diabetes, Type 1 Trial (Golimumab, Placebo)

      Withdrawn
      • Diabetes Mellitus, Type 1
      • (no location specified)
      Nov 19, 2021